http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-033113-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d9160324b30c6445d9be4da9f41c66e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
filingDate 2014-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f115b05db3af3fab8aca95a5cfd483c9
publicationDate 2019-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-033113-B1
titleOfInvention METHODS FOR TREATING AUTOIMMUNE, RESPIRATORY AND INFLAMMATORY DISORDERS BY INHALATION OF N-OXIDE OF ROFLUMILAST
abstract The present invention provides the use of inhaled pharmaceutical compositions containing roflumilast N-oxide for the treatment of autoimmune, respiratory and / or inflammatory diseases and conditions, and a method for treating these diseases and conditions, including inhalation of roflumilast N-oxide or a pharmaceutically acceptable salt thereof thereof characterized by less than 6 μm and administered as a single dose of about 5 to about 2000 μg.
priorityDate 2013-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004084894-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006270667-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9501338-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006094942-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004047829-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422020808
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9940999

Total number of triples: 37.